Research Article

遗传等位基因与多米尼加共和国西班牙裔患者的SLE易感性和临床表现相关

卷 19, 期 3, 2019

页: [164 - 171] 页: 8

弟呕挨: 10.2174/1566524019666190424130809

价格: $65

摘要

目的:系统性红斑狼疮(SLE)是一种复杂的自身免疫性疾病,不同种族的患病率和疾病严重程度存在显着差异。本研究的目的是描述拉丁美洲队列的特征,并确定在这个拉丁裔西班牙裔队列中发展SLE及其终末器官表现的遗传风险因素。 方法:在多米尼加共和国(DR)招募了201例SLE病例和205例非病变对照。根据1997年修订的美国风湿病学会SLE分类标准确定病例。从全血制备基因组DNA,并应用于42种单核苷酸多态性(SNP)的基因分型分析,所述单核苷酸多态性与其他种族群体中的自身免疫疾病(包括SLE)有关。通过Fisher''s Exact Probability Test分析数据。 结果:在该队列中,SNP rs9271366(HLA-DRB1 * 15:01的标签SNP)在显示与SLE相关的13个MHC基因等位基因中赋予最高的SLE风险(p = 8.748E-10; OR = 3.5)。在分析的26个非MHC基因等位基因中,PTPN22基因中的SNP rs2476601赋予SLE最高风险(p = 0.0001; OR = 5.6)。在DR组中,ITGAM,TNFSF4,TNIP1,STAT4,CARD11,BLK和TNXB基因等位基因被确认为SLE易感等位基因。然而,IRF5和TNFAIP3基因等位基因是欧洲和亚洲血统人群中SLE的既定危险因素,在该队列中与SLE无显着相关性。我们还定义了一种新型HLA-DRA单倍型,它可以增加狼疮性肾炎(LN)和HLA-DRA2和TNFSF4基因等位基因的风险,作为发展神经精神(NP)SLE的遗传风险因素。 结论:我们的数据表明,拉丁美洲人群与其他人群一样具有SLE的一些常见遗传风险因子,但也有明显的风险基因等位基因,这些基因等位基因有助于SLE易感性和LN和NPSLE的发展。这是第一项关注DR中SLE遗传风险因素的研究,这是一种前所未有的拉丁美洲人群。

关键词: 遗传等位基因狼疮,系统性红斑狼疮,SLE,遗传等位基因,西班牙裔患者,遗传危险因素,自身免疫性疾病。

[1]
Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008; 358(9): 929-39.
[2]
Tsokos GC. Systemic lupus erythematosus. N Engl J Med 2011; 365(22): 2110-21.
[3]
Fernandez M, Alarcon GS, Calvo-Alen J, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 2007; 57(4): 576-84.
[4]
Uribe AG, McGwin G, Jr Reveille JD, Alarcon GS. What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading? Autoimmun Rev 2004; 3(4): 321-9.
[5]
Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. Am J Med 1991; 91(4): 345-53.
[6]
Reveille JD, Moulds JM, Ahn C, et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998; 41(7): 1161-72.
[7]
Ceccarelli F, Perricone C, Borgiani P, et al. Genetic factors in systemic lupus erythematosus: Contribution to disease phenotype. J Immunol Res 2015; 2015745647
[8]
Goulielmos GN, Zervou MI, Vazgiourakis VM, Ghodke-Puranik Y, Garyfallos A, Niewold TB. The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry. Gene 2018; 668: 59-72.
[9]
James JA. Clinical perspectives on lupus genetics: Advances and opportunities. Rheum Dis Clin North Am 2014; 40(3): 413-32. vii.
[10]
Rosetti F, de la Cruz A, Crispin JC. Gene-function studies in systemic lupus erythematosus. Curr Opin Rheumatol 2019; 31(2): 185-92.
[11]
Teruel M, Alarcon-Riquelme ME. The genetic basis of systemic lupus erythematosus: What are the risk factors and what have we learned. J Autoimmun 2016; 74: 161-75.
[12]
Teruel M, Alarcon-Riquelme ME. Genetics of systemic lupus erythematosus and sjogren’s syndrome: An update. Curr Opin Rheumatol 2016; 28(5): 506-14.
[13]
Yuan YJ, Luo XB, Shen N. Current advances in lupus genetic and genomic studies in Asia. Lupus 2010; 19(12): 1374-83.
[14]
Pons-Estel GJ, Catoggio LJ, Cardiel MH, et al. Lupus in latin-american patients: Lessons from the GLADEL cohort. Lupus 2015; 24(6): 536-45.
[15]
Lu R, Robertson JM, Bruner BF, et al. Multiple autoantibodies display association with lymphopenia, proteinuria, and cellular casts in a large, ethnically diverse SLE patient cohort. Autoimmune Dis 2012; 2012819634
[16]
Morris DL, Taylor KE, Fernando MM, et al. Unraveling multiple MHC gene associations with systemic lupus erythematosus: Model choice indicates a role for HLA alleles and non-HLA genes in europeans. Am J Hum Genet 2012; 91(5): 778-93.
[17]
Fernando MM, Stevens CR, Sabeti PC, et al. Identification of two independent risk factors for lupus within the MHC in united kingdom families. PLoS Genet 2007; 3(11)e192
[18]
Kitajima H, Sonoda M, Yamamoto K. HLA and SNP haplotype mapping in the japanese population. Genes Immun 2012; 13(7): 543-8.
[19]
Namjou B, Kim-Howard X, Sun C, et al. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. PLoS One 2013; 8(8)e69404
[20]
Hom G, Graham RR, Modrek B, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008; 358(9): 900-9.
[21]
Kawasaki A, Ito I, Hikami K, et al. Role of STAT4 polymorphisms in systemic lupus erythematosus in a japanese population: A case-control association study of the STAT1-STAT4 region. Arthritis Res Ther 2008; 10(5): R113.
[22]
Gateva V, Sandling JK, Hom G, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009; 41(11): 1228-33.
[23]
Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a chinese han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009; 41(11): 1234-7.
[24]
Adrianto I, Wang S, Wiley GB, et al. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum 2012; 64(11): 3695-705.
[25]
Julia A, Lopez-Longo FJ, Venegas PJJ, et al. Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus. Arthritis Res Ther 2018; 20(1): 100.
[26]
Ramos PS, Brown EE, Kimberly RP, Langefeld CD. Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol 2010; 30(2): 164-76.
[27]
Wunnenburger S, Schultheiss UT, Walz G, et al. Associations between genetic risk variants for kidney diseases and kidney disease etiology. Sci Rep 2017; 7(1): 13944.
[28]
Xu R, Li Q, Liu R, et al. Association analysis of the MHC in lupus nephritis. J Am Soc Nephrol 2017; 28(11): 3383-94.
[29]
Ruiz-Narvaez EA, Fraser PA, Palmer JR, et al. MHC region and risk of systemic lupus erythematosus in african american women. Hum Genet 2011; 130(6): 807-15.
[30]
Barcellos LF, May SL, Ramsay PP, et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 2009; 5(10)e1000696
[31]
Pons-Estel BA, Catoggio LJ, Cardiel MH, et al. The GLADEL multinational latin american prospective inception cohort of 1,214 patients with systemic lupus erythematosus: Ethnic and disease heterogeneity among “Hispanics”. Medicine (Baltimore) 2004; 83(1): 1-17.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy